Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,037 public trials 564 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Active, Not Recruiting

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

NCT03896737

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
Locations
  • Hradec Kralove-University Hospital Hradec Kralove Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Ostrava Ostrava, Czechia
  • University Hospital Ostrava Ostrava, Czechia
View all 24 locations
View Trial Details
Active, Not Recruiting

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

NCT04564703

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Bordeau, France
  • Centre Hospitalier Universitaire de Dijon Dijon, France
  • CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE Nantes, France
  • CHU Hôtel-Dieu Nantes, France
View all 22 locations
View Trial Details
Active, Not Recruiting

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)

NCT04483739

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Het Ziekenhuisnetwerk Antwerpen - Department of Hematology Antwerp, Belgium
  • Fakultni Nemocnice Brno - Internal Hematology and Oncology Clinic Brno, Czechia
  • Fakultni Nemocnice Hradec Kralove - 4th Department of Internal Medicine Nový Hradec Králové, Czechia
  • Fakultni Nemocnice Ostrava - Department of Haematooncology Ostrava, Czechia
View all 41 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

NCT06413498

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital Gilbert, Arizona, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 117 locations
View Trial Details

Related conditions